Form 4 for GTBP GT Biopharma, Inc.
Accepted 2022-07-19 00:00:00 ET · period of report 2022-07-15 · accession 0001493152-22-019872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.00 | -100.0K | 0 | -100% | $0 |
| DI | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | J - Other | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2022-07-19 | 2022-07-15 | GTBP | Ohri Manu | CFO, Sec | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-15 | A | A | 100,000 | $0.00 | 100,000 | D By Anarjay Concepts, Inc. | — | — | |
| 2 | Common | Common Stock | 2022-07-15 | J | D | 100,000 | $0.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-15 | J | A | 100,000 | $0.00 | 100,000 | I | — | — | |
| 4 | Derivative | Option to purchase Common Stock | 2022-07-15 | A | A | 200,000 | $0.00 | 200,000 | D | $2.48 · — to 2032-07-14 | 200,000 Common Stock | (F2) 66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024. |